BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 35031594)

  • 1. Prediction of Patient Survival with Psoas Muscle Density Following Transjugular Intrahepatic Portosystemic Shunts: A Retrospective Cohort Study.
    Zhang B; Cai W; Gao F; Lin X; Qian T; Gu K; Song B; Chen T
    Med Sci Monit; 2022 Jan; 28():e934057. PubMed ID: 35031594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoas Muscle Density in Combination with Model for End-Stage Liver Disease Score Can Improve Survival Predictability in Transjugular Intrahepatic Portosystemic Shunts.
    Shoreibah MG; Mahmoud K; Aboueldahab NA; Vande Lune P; Massoud M; Bae S; El Khudari H; Gunn AJ; Abdel Aal AK
    J Vasc Interv Radiol; 2019 Feb; 30(2):154-161. PubMed ID: 30717946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoas Muscle Density Predicts Occurrences of Hepatic Encephalopathy in Patients Receiving Transjugular Intrahepatic Portosystemic Shunts within 1 year.
    Cai W; Lin H; Qi R; Lin X; Zhao Y; Chen W; Huang Z
    Cardiovasc Intervent Radiol; 2022 Jan; 45(1):93-101. PubMed ID: 34523022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
    Wang Z; Wu YF; Yue ZD; Zhao HW; Wang L; Fan ZH; Zhang Y; Liu FQ
    World J Gastroenterol; 2021 Feb; 27(5):416-427. PubMed ID: 33584073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of sarcopenia predicts survival after a transjugular intrahepatic portosystemic stent.
    Tsien C; Shah SN; McCullough AJ; Dasarathy S
    Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):85-93. PubMed ID: 23011041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation.
    Gaba RC; Couture PM; Bui JT; Knuttinen MG; Walzer NM; Kallwitz ER; Berkes JL; Cotler SJ
    J Vasc Interv Radiol; 2013 Mar; 24(3):411-20, 420.e1-4; quiz 421. PubMed ID: 23312989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inclusion of sarcopenia improves the prognostic value of MELD score in patients after transjugular intrahepatic portosystemic shunt.
    Bai YW; Liu JC; Yang CT; Wang YL; Wang CY; Ju SG; Zhou C; Huang SJ; Li TQ; Chen Y; Yao W; Xiong B
    Eur J Gastroenterol Hepatol; 2022 Sep; 34(9):948-955. PubMed ID: 35594511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MELD or Sodium MELD: A Comparison of the Ability of Two Scoring Systems to Predict Outcomes After Transjugular Intrahepatic Portosystemic Shunt Placement.
    Young S; Rostambeigi N; Golzarian J; Lim N
    AJR Am J Roentgenol; 2020 Jul; 215(1):215-222. PubMed ID: 32432911
    [No Abstract]   [Full Text] [Related]  

  • 9. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt.
    Salerno F; Merli M; Cazzaniga M; Valeriano V; Rossi P; Lovaria A; Meregaglia D; Nicolini A; Lubatti L; Riggio O
    J Hepatol; 2002 Apr; 36(4):494-500. PubMed ID: 11943420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of mortality after emergent transjugular intrahepatic portosystemic shunt placement: use of APACHE II, Child-Pugh and MELD scores in Asian patients with refractory variceal hemorrhage.
    Tzeng WS; Wu RH; Lin CY; Chen JJ; Sheu MJ; Koay LB; Lee C
    Korean J Radiol; 2009; 10(5):481-9. PubMed ID: 19721833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validating the prognostic value of Freiburg index of posttransjugular intrahepatic portosystemic shunt survival score and classic scores in Chinese patients with implantation of transjugular intrahepatic portosystemic shunt.
    Song J; Wang X; Yan Y; Xiang T; Luo X
    Eur J Gastroenterol Hepatol; 2022 Oct; 34(10):1074-1080. PubMed ID: 36062497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt.
    Praktiknjo M; Clees C; Pigliacelli A; Fischer S; Jansen C; Lehmann J; Pohlmann A; Lattanzi B; Krabbe VK; Strassburg CP; Arroyo V; Merli M; Meyer C; Trebicka J
    Clin Transl Gastroenterol; 2019 Apr; 10(4):e00025. PubMed ID: 30939488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting.
    Schepke M; Roth F; Fimmers R; Brensing KA; Sudhop T; Schild HH; Sauerbruch T
    Am J Gastroenterol; 2003 May; 98(5):1167-74. PubMed ID: 12809844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different scoring systems in predicting survival in Chinese patients with liver cirrhosis undergoing transjugular intrahepatic portosystemic shunt.
    Zhang F; Zhuge Y; Zou X; Zhang M; Peng C; Li Z; Wang T
    Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):853-60. PubMed ID: 24915489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.
    Bettinger D; Sturm L; Pfaff L; Hahn F; Kloeckner R; Volkwein L; Praktiknjo M; Lv Y; Han G; Huber JP; Boettler T; Reincke M; Klinger C; Caca K; Heinzow H; Seifert LL; Weiss KH; Rupp C; Piecha F; Kluwe J; Zipprich A; Luxenburger H; Neumann-Haefelin C; Schmidt A; Jansen C; Meyer C; Uschner FE; Brol MJ; Trebicka J; Rössle M; Thimme R; Schultheiss M
    J Hepatol; 2021 Jun; 74(6):1362-1372. PubMed ID: 33508376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of radiologically determined muscle area in patients with liver cirrhosis after transjugular intrahepatic portosystemic shunt.
    March C; Thormann M; Geipel S; Sowa JP; Barajas Ordonez F; Pech M; Omari J; Lemmer P
    Sci Rep; 2023 Oct; 13(1):17092. PubMed ID: 37816875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
    Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
    Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MELD 3.0 Score for Predicting Survival in Patients with Cirrhosis After Transjugular Intrahepatic Portosystemic Shunt Creation.
    Song J; Wang X; Yan Y; Xiang T; Luo X
    Dig Dis Sci; 2023 Jul; 68(7):3185-3192. PubMed ID: 36715817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albumin-bilirubin grade versus MELD score for predicting survival after transjugular intrahepatic portosystemic shunt (TIPS) creation.
    Ronald J; Wang Q; Choi SS; Suhocki PV; Hall MD; Smith TP; Kim CY
    Diagn Interv Imaging; 2018 Mar; 99(3):163-168. PubMed ID: 29154015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcopenia Defined by Psoas Muscle Thickness Predicts Mortality After Transjugular Intrahepatic Portosystemic Shunt.
    Li T; Liu J; Zhao J; Bai Y; Huang S; Yang C; Wang Y; Zhou C; Wang C; Ju S; Chen Y; Yao W; Xiong B
    Dig Dis Sci; 2023 Apr; 68(4):1641-1652. PubMed ID: 36583804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.